Interestingly, breast cancer treatment with chemotherapeutic agents has been found to increase CAEC-derived production of tumor necrosis factor (TNF)-alpha, causing an increase in production of CXCL1/2 via nuclear factor (NF)-kappaB by the cancer cells [24]. This evidence concerns the gene CXCL1 and breast carcinoma.